Surrozen, Inc. (SRZN) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Surrozen, Inc. (SRZN).

Download StockRank on Google Play Download StockRank on the App Store

Equity Overview

Price & Market Data

Price: $9.03

Daily Change: -$1.33 / 14.72%

Daily Range: $9.03 - $10.15

Market Cap: $77,320,096

Daily Volume: 8,287

Performance Metrics

1 Week: -9.70%

1 Month: 8.53%

3 Months: -2.38%

6 Months: -20.23%

1 Year: 23.02%

YTD: -37.07%

Company Details

Employees: 41

Sector: Health technology

Industry: Biotechnology

Country:

Details

Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics that target various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. The company develops SZN-814, which combines Frizzled 4 (Fzd4 agonism) and vascular endothelial growth factor (VEGF antagonism) to treat diabetic macular edema (DME), neovascular age-related macular degeneration (wet AMD), and retinopathy indications; SZN-8143, which combines Fzd4 agonism, VEGF antagonism, and interleukin-6 for the treatment of DME/wet AMD/uveitic macular edema; SZN-113 to treat Fuchs' endothelial corneal dystrophy and geographic atrophy; and SZN-413, a Fzd4 targeted bi-specific antibody for the treatment of retinal vascular associated diseases. Surrozen, Inc. has a collaboration and license agreement with Boehringer Ingelheim International GmbH to research, develop, and commercialize Fzd4 bi-specific antibodies; and a research collaboration agreement with TCGFB, Inc. to discover antibody therapeutics targeting transforming growth factor beta, or TGF-ß, for the treatment of pulmonary fibrosis. Surrozen, Inc. is headquartered in South San Francisco, California.

Selected stocks

AquaBounty Technologies, Inc. (AQB)

Moderna, Inc. (MRNA)

ENDRA Life Sciences Inc. (NDRA)